Apeloa Pharmaceutical Co Ltd (000739) — Free Cash Flow Generation Index
Apeloa Pharmaceutical Co Ltd (000739) has a Free Cash Flow Generation Index of 0.63x as of December 2025. Free cash flow of CN¥279.45 Million represents 1% of operating cash flow (CN¥446.18 Million). Explore Apeloa Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Apeloa Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see 000739 operating cash flow.
Annual Free Cash Flow Generation for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Apeloa Pharmaceutical Co Ltd. Check Apeloa Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥844.46 Million | CN¥1.23 Billion | CN¥386.21 Million | ▲ +10.9% |
| 2024 | 0.62x | CN¥748.01 Million | CN¥1.21 Billion | CN¥460.75 Million | ▲ +59.2% |
| 2023 | 0.39x | CN¥400.90 Million | CN¥1.03 Billion | CN¥630.47 Million | ▼ -36.9% |
| 2022 | 0.62x | CN¥817.00 Million | CN¥1.33 Billion | CN¥509.11 Million | ▲ +518.0% |
| 2021 | -0.15x | CN¥-90.18 Million | CN¥611.75 Million | CN¥701.92 Million | ▼ -121.0% |
| 2020 | 0.70x | CN¥742.41 Million | CN¥1.06 Billion | CN¥317.12 Million | ▼ -28.2% |
| 2019 | 0.98x | CN¥1.33 Billion | CN¥1.36 Billion | CN¥31.85 Million | ▲ +8.3% |
| 2018 | 0.90x | CN¥751.07 Million | CN¥832.69 Million | CN¥81.62 Million | ▲ +308.0% |
| 2017 | 0.22x | CN¥46.38 Million | CN¥209.80 Million | CN¥163.42 Million | ▲ +126.4% |
| 2016 | -0.84x | CN¥-150.93 Million | CN¥180.42 Million | CN¥331.35 Million | ▼ -3285.0% |
| 2015 | -0.02x | CN¥-10.90 Million | CN¥441.16 Million | CN¥452.06 Million | ▼ -107.9% |
| 2014 | 0.31x | CN¥246.42 Million | CN¥786.64 Million | CN¥540.22 Million | ▲ +119.0% |
| 2013 | -1.65x | CN¥-314.56 Million | CN¥190.45 Million | CN¥505.01 Million | ▼ -14928.1% |
| 2012 | -0.01x | CN¥-3.69 Million | CN¥335.90 Million | CN¥339.59 Million | ▲ +95.9% |
| 2011 | -0.27x | CN¥-107.47 Million | CN¥404.62 Million | CN¥289.21 Million | ▼ -71.4% |
| 2010 | -0.15x | CN¥-18.76 Million | CN¥121.05 Million | CN¥139.81 Million | ▼ -128.2% |
| 2009 | 0.55x | CN¥114.64 Million | CN¥208.30 Million | CN¥93.66 Million | ▲ +120.5% |
| 2008 | -2.69x | CN¥-254.47 Million | CN¥94.57 Million | CN¥349.04 Million | ▼ -901.3% |
| 2007 | 0.34x | CN¥58.50 Million | CN¥174.20 Million | CN¥115.70 Million | ▼ -49.3% |
| 2006 | 0.66x | CN¥105.58 Million | CN¥159.43 Million | CN¥53.84 Million | ▲ +269.0% |
| 2005 | -0.39x | CN¥-34.26 Million | CN¥87.40 Million | CN¥121.65 Million | ▲ +70.7% |
| 2004 | -1.34x | CN¥-63.52 Million | CN¥47.54 Million | CN¥111.07 Million | ▼ -915.2% |
| 2003 | 0.16x | CN¥17.27 Million | CN¥105.36 Million | CN¥88.09 Million | ▲ +101.0% |
| 2002 | -15.78x | CN¥-44.42 Million | CN¥2.81 Million | CN¥47.23 Million | ▼ -2991.4% |
| 2000 | 0.55x | CN¥3.86 Million | CN¥7.08 Million | CN¥3.22 Million | ▲ +20.2% |
| 1998 | 0.45x | CN¥13.66 Million | CN¥30.10 Million | CN¥16.43 Million | — |